Dr Maria Agustina Perusini speaks to ecancer at the ASH 2019 meeting in Orlando.

She discusses the challenges associated with accessing drugs and performing specific diagnostic procedures such as next-generation sequencing (NGS) for patients with acute leukaemia and myelodysplastic syndromes.

Dr Perusini also notes the importance of attending meetings like ASH, which provide opportunities for training and collaboration.